Fresenius SE & Co KGaA (FRA:FRE) has been given a €37.50 ($43.60) target price by Sanford C. Bernstein in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Sanford C. Bernstein’s target price points to a potential upside of 11.61% from the stock’s current price.

A number of other analysts have also issued reports on the company. DZ Bank reaffirmed a “buy” rating on shares of Fresenius SE & Co KGaA in a research note on Monday. Berenberg Bank set a €72.10 ($83.84) price target on Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Monday, February 24th. Independent Research set a €54.00 ($62.79) price target on Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a research note on Monday, February 24th. Kepler Capital Markets set a €62.00 ($72.09) price target on Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Friday, March 20th. Finally, JPMorgan Chase & Co. set a €59.40 ($69.07) price target on Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Thursday, February 20th. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Fresenius SE & Co KGaA presently has an average rating of “Buy” and an average target price of €55.67 ($64.73).

Shares of FRA:FRE opened at €33.60 ($39.07) on Tuesday. The business’s 50 day moving average price is €41.16 and its 200-day moving average price is €45.61. Fresenius SE & Co KGaA has a 1 year low of €60.16 ($69.95) and a 1 year high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

See Also: Dead Cat Bounce

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.